Michael David Garrison
At a glance: Michael David Garrison is Evp & Pres Med.Essntl&Biopharm at Becton Dickinson (BDX). Their latest SEC Form 4, filed Jun 25, 2026, reported a sale of $160K. On file: 0 purchase lines ($0) and 5 sale lines ($784K).
Disclosed holdings: about $2.8M of BDX stock: 13,172 shares reported on their latest Form 4 (filed Jun 25, 2026), valued at the Nov 20, 2026 close of $214.28. This counts only BDX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp & Pres Med.Essntl&Biopharm at Becton Dickinson & Co (BDX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Michael David Garrison's InsiderPrint
5 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 5 times a year, typically $160K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (5)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Keelan AdamsonCEO, President · RIG · 100% match
- Erika Ashley FisherGeneral Counsel · HUBS · 100% match
- Christopher Michael RyanCOO, President · GEVO · 100% match
- Steve PakolaChief Medical Officer · RGNX · 100% match
- Mark A. MarinoCFO · RXT · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 25SEC | BDXBecton Dickinson & Co | Sell Plan | 1,10013,172 held (−8%) | $145.66 | $160K | +47.1% |
| Jun 11SEC | BDXBecton Dickinson & Co | Sell Plan | 1,10014,272 held (−7%) | $151.48 | $167K | +41.5% |
| Jan 16SEC | BDXBecton Dickinson & Co | Sell Plan | 60013,105 held (−4%) | $209.00 | $125K | +2.5% |
| Jan 16SEC | BDXBecton Dickinson & Co | Sell Plan | 1,01012,095 held (−8%) | $206.54 | $209K | +3.7% |
| Dec 17SEC | BDXBecton Dickinson & Co | Sell Plan | 62913,105 held (−5%) | $196.03 | $123K | +9.3% |
- Sell
Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $160K of BDX at $145.66 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $167K of BDX at $151.48 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $125K of BDX at $209.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $209K of BDX at $206.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $123K of BDX at $196.03 — pre-scheduled 10b5-1 plan sale.
Follow Michael David Garrison
Get one email when Michael David Garrison files a new purchase or sale. Free.
At most one email a day about Michael David Garrison, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.